Ignite Creation Date:
2024-05-05 @ 5:32 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00479817
Status:
COMPLETED
Last Update Posted:
2019-12-18
First Post:
2007-05-24
Brief Title:
Phase 2 AMG 386 in Comb Paclitaxel for Subjects With Advanced Recurrent Epithelial Ovarian or Primary Peritoneal Cancer
Sponsor:
Organization:
Amgen